Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cellular Immunology

• Publication date

  2017-09-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cellimm.2017.08.009PMID 28919171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis

  2018cited by this paper
• Clinical Trial of Human Umbilical Cord Blood‐Derived Stem Cells for the Treatment of Moderate‐to‐Severe Atopic Dermatitis: Phase I/IIa Studies

  2017cited by this paper
• ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells

  2017cited by this paper
• Intravenous hMSCs Ameliorate Acute Pancreatitis in Mice via Secretion of Tumor Necrosis Factor-α Stimulated Gene/Protein 6

  2016cited by this paper
• The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease – a phase 1 trial with three doses

  2016cited by this paper
• Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment

  2016cited by this paper
• Problems and Solutions in Click Chemistry Applied to Drug Probes

  2016cited by this paper
• Implications of mesenchymal stem cells in regenerative medicine

  2016cited by this paper
• Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells.

  2016cited by this paper
• Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cells Induces a Switch from Classical to Atypical Symptoms in Experimental Autoimmune Encephalomyelitis

  2015cited by this paper
• Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow-Derived Mesenchymal Stem Cells.

  2015cited by this paper
• Adipose Tissue-Derived Mesenchymal Stem Cells Induce Expansion of Interleukin-10-Producing Regulatory B Cells and Ameliorate Autoimmunity in a Murine Model of Systemic Lupus Erythematosus

  2015cited by this paper
• Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study

  2015cited by this paper
• Human Adipose Tissue‐Derived Mesenchymal Stem Cells Abrogate Plasmablast Formation and Induce Regulatory B Cells Independently of T Helper Cells

  2015cited by this paper
• The cell‐surface proteome of cultured adipose stromal cells

  2015cited by this paper
• Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes Mellitus

  2015cited by this paper
• Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.

  2015cited by this paper
• Manufacture of Clinical-Grade Human Clonal Mesenchymal Stem Cell Products from Single Colony Forming Unit-Derived Colonies Based on the Subfractionation Culturing Method

  2015cited by this paper
• Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion

  2015cited by this paper
• Bone Marrow Mesenchymal Stromal Cells to Treat Tissue Damage in Allogeneic Stem Cell Transplant Recipients: Correlation of Biological Markers with Clinical Responses

  2014cited by this paper
• Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10

  2014influential reference
• Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.

  2014cited by this paper
• Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells.

  2014cited by this paper
• Cellular targets of regulatory B cell-mediated suppression.

  2014cited by this paper
• Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs)

  2014cited by this paper
• Toll like Receptor 3 & 4 Responses of Human Turbinate Derived Mesenchymal Stem Cells: Stimulation by Double Stranded RNA and Lipopolysaccharide

  2014cited by this paper
• Modulation properties of factors released by bone marrow stromal cells on activated microglia: an in vitro study

  2014cited by this paper
• New insights in the pathogenesis of atopic dermatitis

  2014cited by this paper
• Clinical Applications of Mesenchymal Stem Cells in Chronic Diseases

  2014cited by this paper
• Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells

  2014cited by this paper
• Bone marrow-derived clonal mesenchymal stem cells inhibit ovalbumin-induced atopic dermatitis

  2014cited by this paper
• Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis

  2014cited by this paper
• Adult adherent stromal cells in the management of graft-versus-host disease

  2014cited by this paper
• Isolation of adipose-derived stem cells by using a subfractionation culturing method

  2014cited by this paper
• A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.

  2014cited by this paper
• Mesenchymal Stem Cells Differentially Modulate Effector CD8+ T Cell Subsets and Exacerbate Experimental Autoimmune Encephalomyelitis

  2014influential reference
• Interplay of autophagy and innate immunity in Crohn's disease: a key immunobiologic feature.

  2013cited by this paper
• NK and MSCs Crosstalk: The Sense of Immunomodulation and Their Sensitivity

  2013cited by this paper
• Mechanisms of mesenchymal stromal cell immunomodulation

  2013cited by this paper
• Multipotent stromal cells skew monocytes towards an anti-inflammatory function: the link with key immunoregulatory molecules

  2013cited by this paper
• B‐regulatory cells in autoimmunity and immune mediated inflammation

  2013cited by this paper
• Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: Preliminary results

  2013cited by this paper
• Uptake and delivery of antigens by mesenchymal stromal cells.

  2013cited by this paper
• Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model.

  2013cited by this paper
• In vitro generation of glucose-responsive insulin producing cells using lentiviral based pdx-1 gene transduction of mouse (C57BL/6) mesenchymal stem cells.

  2013cited by this paper
• Mesenchymal stromal cells: misconceptions and evolving concepts.

  2013cited by this paper
• Interactions between mesenchymal stem cells and dendritic cells.

  2013cited by this paper
• Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review

  2013cited by this paper
• Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling.

  2012cited by this paper
• Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis.

  2012influential reference
• Immune regulatory function of B cells.

  2012cited by this paper
• Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.

  2012cited by this paper
• Immunomodulatory Function of Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells

  2012cited by this paper
• Toll-Like Receptors as Modulators of Mesenchymal Stem Cells

  2012cited by this paper
• Immunomodulatory Effect of Mesenchymal Stem Cells on B Cells

  2012cited by this paper
• How mesenchymal stem cells interact with tissue immune responses.

  2012cited by this paper
• Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.

  2012cited by this paper
• The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth

  2012cited by this paper
• Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications

  2012cited by this paper
• Repetitive Intrathecal Catheter Delivery of Bone Marrow Mesenchymal Stromal Cells Improves Functional Recovery in a Rat Model of Contusive Spinal Cord Injury

  2011cited by this paper
• Multiple Sclerosis: Pathogenesis and Treatment

  2011cited by this paper
• Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats.

  2011influential reference
• B cell-directed therapies in type 1 diabetes.

  2011cited by this paper
• The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells.

  2011cited by this paper
• Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.

  2011cited by this paper
• The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

  2011cited by this paper
• Mesenchymal stem cell effects on T-cell effector pathways

  2011cited by this paper
• Mesenchymal Stem Cells in Tissue Growth and Repair

  2011cited by this paper
• Mesenchymal stromal cell ‘licensing’: a multistep process

  2011cited by this paper
• Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

  2011cited by this paper
• Immune cell crosstalk in type 1 diabetes

  2010cited by this paper
• Role of the innate immune system in the pathogenesis of multiple sclerosis.

  2010cited by this paper
• Genetics, pathogenesis and clinical interventions in type 1 diabetes

  2010cited by this paper
• Multiple sclerosis immunology

  2010cited by this paper
• Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression

  2010cited by this paper
• A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype

  2010cited by this paper
• IL-6-Dependent PGE2 Secretion by Mesenchymal Stem Cells Inhibits Local Inflammation in Experimental Arthritis

  2010cited by this paper
• Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.

  2010cited by this paper
• Umbilical Cord-Derived Mesenchymal Stromal Cells Modulate Monocyte Function to Suppress T Cell Proliferation

  2010cited by this paper
• Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study.

  2010cited by this paper
• Mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease: a report of two cases

  2010cited by this paper
• Essential role of monocytes and macrophages in the progression of acute pancreatitis.

  2010cited by this paper
• Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.

  2010cited by this paper
• Prochymal Improves Response Rates In Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-GVHD) Involving The Liver And Gut: Results Of A Randomized, Placebo-Controlled, Multicenter Phase III Trial In GVHD

  2010cited by this paper
• Pathogenesis and management of graft-versus-host disease.

  2010cited by this paper
• Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

  2010cited by this paper
• Acute pancreatitis: etiology and common pathogenesis.

  2009cited by this paper
• Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

  2009cited by this paper
• Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells

  2009cited by this paper
• MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

  2009cited by this paper
• Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.

  2008cited by this paper
• IFNγ and B7-H1 in the immunology of mesenchymal stem cells

  2008cited by this paper
• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008cited by this paper
• Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

  2008cited by this paper
• T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis

  2008cited by this paper
• Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells

  2008influential reference
• Macrophage activation and polarization.

  2008cited by this paper
• Variations of Clonal Marrow Stem Cell Lines Established from Human Bone Marrow in Surface Epitopes, Differentiation Potential, Gene Expression, and Cytokine Secretion

  2008cited by this paper
• A critical role of IFNγ in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1

  2008cited by this paper
• Mesenchymal stem cells inhibit natural killer – cell proliferation , cytotoxicity , and cytokine production : role of indoleamine 2 , 3-dioxygenase and prostaglandin E 2

  2008cited by this paper

• Whispers of Growth: The Impact of MicroRNA on the Proliferation Potential of Adipose‐Derived Stem Cells—A Review

  2026cites this paper
• MSCs-derived CRABP2 regulates Treg/CXCL1 to ameliorate alcohol-induced liver injury

  2026cites this paper
• A systematic review of published clinical studies using cell-derived extracellular vesicles: A focus on efficacy in COVID-19 and wound healing.

  2025cites this paper
• Preventing MSC aging and enhancing immunomodulation: Novel strategies for cell-based therapies

  2025cites this paper
• Umbilical cord mesenchymal stem cells and their secretome in peripheral nerve regeneration: a narrative review promising therapeutic strategy

  2025cites this paper
• Natural, Engineered, and Hybrid Platelet Membrane–Based Nanotherapeutics for Inflammatory Diseases

  2025cites this paper
• Distinct biological characteristics of mesenchymal stem cells separated from different components of human placenta

  2024cites this paper
• Caught in action: how MSCs modulate atherosclerotic plaque

  2024cites this paper
• Regulatory B cells in autoimmune diseases: Insights and therapeutic potential.

  2024cites this paper
• Efficacy of adipose tissue-derived stromal fraction in the treatment of osteochondral defects in rabbits

  2024cites this paper
• Mesenchymal stem cells alleviate inflammatory responses through regulation of T-cell subsets.

  2024cites this paper
• Human bone marrow-derived clonal mesenchymal stem cells decrease the initial C-reactive protein level in patients with moderately severe to severe acute pancreatitis.

  2023cites this paper
• COVID-19 disease treatment: pivotal challenges in the arena of umbilical cord-mesenchymal stem cells (UC-MSCs)

  2023influential citation
• Stem cells as a therapeutic choice in dermatological disorders.

  2022cites this paper
• Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells

  2022cites this paper
• Targeted delivery of platelet membrane modified extracellular vesicles into atherosclerotic plaque to regress atherosclerosis

  2022cites this paper
• Cellular Therapeutics for Chronic Wound healing: Future for Regenerative Medicine.

  2022cites this paper
• Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis

  2022influential citation
• Understanding the Transcriptomic Landscape to Drive New Innovations in Musculoskeletal Regenerative Medicine

  2022cites this paper
• Expression of immunomodulatory and tissue regenerative biomarkers in human dental pulp derived-mesenchymal stem cells treated with curcumin: an in vitro study

  2022cites this paper
• Enhancing and stabilization of cord blood regulatory T cell suppressive function by human mesenchymal stem cell (MSC)-derived exosomes.

  2022cites this paper
• Peripheral Blood-Derived Mesenchymal Stem Cells Modulate Macrophage Plasticity through the IL-10/STAT3 Pathway

  2022cites this paper
• Treatment with hepatocyte transplantation in a novel mouse model of persistent liver failure

  2022cites this paper
• COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions

  2021cites this paper
• Angiogenesis in Regenerative Dentistry: Are We Far Enough for Therapy?

  2021cites this paper
• Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series

  2021cites this paper
• Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell

  2021cites this paper
• Immunomodulatory Activity of Human Bone Marrow and Adipose-Derived Mesenchymal Stem Cells Prolongs Allogenic Skin Graft Survival in Nonhuman Primates

  2021cites this paper
• In-vitro Evaluation of Effects of Mesenchymal Stem Cells on TLR3, TLR7/8 and TLR9-activated Natural Killer Cells

  2021cites this paper
• Strategies to address mesenchymal stem/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies.

  2021cites this paper
• Comparison of mesenchymal stromal cells from peritoneal dialysis effluent with those from umbilical cords: characteristics and therapeutic effects on chronic peritoneal dialysis in uremic rats

  2021cites this paper
• Mesenchymal Stem Cell Protects Injured Renal Tubular Epithelial Cells by Regulating mTOR-Mediated Th17/Treg Axis

  2021cites this paper
• Mechanisms underlying the therapeutic potential of mesenchymal stem cells in atherosclerosis.

  2021cites this paper
• In vitro evaluation of periapical lesion‐derived stem cells for dental pulp tissue engineering

  2021cites this paper
• Comparison of mesenchymal stromal cells from peritoneal dialysis e�uent with those from umbilical cords: Characteristics and therapeutic effects on chronic peritoneal dialysis in uremic rats

  2021cites this paper
• Platelets Facilitate the Wound-Healing Capability of Mesenchymal Stem Cells by Mitochondrial Transfer and Metabolic Reprogramming.

  2020cites this paper
• Human fetal liver MSCs are more effective than adult bone marrow MSCs for their immunosuppressive, immunomodulatory, and Foxp3+ T reg induction capacity

  2020cites this paper
• Mesenchymal Stem Cells Activate the MEK/ERK Signaling Pathway and Enhance DNA Methylation via DNMT1 in PBMC from Systemic Lupus Erythematosus

  2020cites this paper
• Bioactive Fibrin Scaffolds for Use in Musculoskeletal Regenerative Medicine

  2020cites this paper
• Effect of Intra-Articular Injection of Chondrocytes Differentiated from Mesenchymal Stem Cells in Monosodium iodoacetate Induced Osteoarthritis in Male Rats

  2020cites this paper
• Modulated mesenchymal stromal cells improve skin wound healing.

  2020cites this paper
• Mesenchymal Stem Cells and Atopic Dermatitis: A Review

  2020cites this paper
• Sirt1-Overexpressing Mesenchymal Stem Cells Drive the Anti-tumor Effect through Their Pro-inflammatory Capacity.

  2020cites this paper
• An update on human periapical cyst-mesenchymal stem cells and their potential applications in regenerative medicine

  2020cites this paper
• Stem Cells Derived from Dental Tissues.

  2019cites this paper
• Mesenchymal Stem Cell Therapy for Spinal Cord Contusion: A Comparative Study on Small and Large Animal Models

  2019cites this paper
• The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity

  2019cites this paper
• Study of the immunomodulatory effects of osteogenic differentiated human dental pulp stem cells

  2019cites this paper
• Protection of the Peritoneal Membrane by Peritoneal Dialysis Effluent-Derived Mesenchymal Stromal Cells in a Rat Model of Chronic Peritoneal Dialysis

  2019cites this paper
• Nanofibrillar cellulose wound dressing supports the growth and characteristics of human mesenchymal stem/stromal cells without cell adhesion coatings

  2019cites this paper
• Harnessing the Properties of Biomaterial to Enhance the Immunomodulation of Mesenchymal Stem Cells

  2019cites this paper
• The Immunomodulatory Potential of Mesenchymal Stem Cells in a Retinal Inflammatory Environment

  2019cites this paper
• Inflammation, mesenchymal stem cells and bone regeneration

  2018influential citation
• Immunomodulatory function of mesenchymal stem cells: regulation and application

  2018cites this paper
• World Journal of Stem Cells

  year unknowncites this paper